Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of mirtazapine in treatment of proteinuria and blood sugar control in diabetic nephropathy
IRCT20160412027346N11Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mirtazapine in diabetic glomerulosclerosis, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Proteinuria reduction and Blood sugar control. Started May 2025; status: completed.
02
Drugs
mirtazapine
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on IRCT20160412027346N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160412027346N11.